Giovanni Benanti

Via Olgettina 60
Milan, 20132, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Targeting type I interferon in lupus panniculitis: a case-based systematic literature review.

Targeting type I interferon in lupus panniculitis: a case-based systematic literature review.

Journal: Rheumatology international

Published: February 16, 2026

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.

Journal: European journal of internal medicine

Published: December 15, 2025

Variability in Post-Discharge Mortality Rates and Predictors over Time: Data from a Five-Year Ward-Wide Study.

Variability in Post-Discharge Mortality Rates and Predictors over Time: Data from a Five-Year Ward-Wide Study.

Journal: Journal of clinical medicine

Published: December 07, 2025

Long-Term Safety of Anti-COVID-19 mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Diseases with a Previous History of Myocarditis.

Long-Term Safety of Anti-COVID-19 mRNA Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Diseases with a Previous History of Myocarditis.

Journal: Microorganisms

Published: August 07, 2025

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study.

Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study.

Journal: European journal of internal medicine

Published: July 03, 2025

Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study.

Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre Study.

Journal: Vaccines

Published: June 09, 2025

Step-down treatment with mepolizumab for eosinophilic granulomatosis with polyangiitis: a real-life single-centre study.

Step-down treatment with mepolizumab for eosinophilic granulomatosis with polyangiitis: a real-life single-centre study.

Journal: Rheumatology (Oxford, England)

Published: January 30, 2025

Infection-Associated Flares in Systemic Lupus Erythematosus.

Infection-Associated Flares in Systemic Lupus Erythematosus.

Journal: Pathogens (Basel, Switzerland)

Published: September 26, 2024

Impact of asthma on severe food-induced allergic reactions: a systematic review and meta-analysis.

Impact of asthma on severe food-induced allergic reactions: a systematic review and meta-analysis.

Journal: European annals of allergy and clinical immunology

Published: June 26, 2024

The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort.

The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort.

Journal: Rheumatology (Oxford, England)

Published: July 22, 2023

Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis.

Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis.

Journal: Expert review of clinical immunology

Published: June 27, 2023

Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination.

Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination.

Journal: Vaccines

Published: January 11, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026